AUSPEX PHARMACEUTICALS INC COM (ASPX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
N/A
Employees:
35
3333 N. TORREY PINES COURT, SUITE 400, LA JOLLA, CA 92037
(858) 558-2400

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Auspex Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing novel medicines for the treatment of orphan diseases.

Data derived from most recent annual or quarterly report
Market Cap 3.077 Billion Shares Outstanding30.48 Million Avg 30-day Volume 637.434 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.69
Price to Revenue0.0 Debt to Equity0.1169 EBITDA-49.086 Million
Price to Book Value13.7889 Operating Margin0.0 Enterprise Value1.543 Billion
Current Ratio13.252 EPS Growth0.993 Quick Ratio12.75
1 Yr BETA 2.7792 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth-279.6744 Altman Z-Score36.9802 Free Cash Flow to Firm -35.026 Million
View SEC Filings from ASPX instead.

View recent insider trading info

AUSPEX PHARMACEUTICALS INC COM YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ASPX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ASPX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD PRIVATE DESIGN FUND II, L.P.

DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.

  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
 No longer subject to file 2015-05-05 0

GREER R SCOTT

  • Director
 No longer subject to file 2015-05-05 0

SCHNEIDER PHILLIP M

  • Director
 No longer subject to file 2015-05-05 0

CHOWRIRA BHARAT M CHIEF OPERATING OFFICER

  • Officer
 No longer subject to file 2015-05-05 0

FERGUSON RODNEY A

  • Director
 No longer subject to file 2015-05-05 0

PROEHL GERALD T

  • Director
 No longer subject to file 2015-05-05 0

SAKS SAMUEL R CHIEF DEVELOPMENT OFFICER

  • Officer
  • Director
 No longer subject to file 2015-05-05 0

THOMAS, MCNERNEY & PARTNERS II, LLC

THOMAS, MCNERNEY & PARTNERS II L.P.

TMP ASSOCIATES II LP

TMP NOMINEE II, LLC

  • Director
  • 10% Owner
 No longer subject to file 2015-05-05 0

STAMLER DAVID A CHIEF MEDICAL OFFICER

  • Officer
 No longer subject to file 2015-05-05 0

SCHMID JOHN P. CHIEF FINANCIAL OFFICER

  • Officer
 No longer subject to file 2015-05-05 0

ZISSON ALEX

  • Director
  • 10% Owner
 No longer subject to file 2015-05-05 0

SHAH PRATIK PRESIDENT AND CEO

  • Officer
  • Director
 No longer subject to file 2015-05-05 0

SARSHAR SEPEHR

  • Director
 No longer subject to file 2015-05-05 0

BLEIL LYNN DORSEY

  • Director
 No longer subject to file 2015-05-05 0

CMEA VENTURES VII LP

CMEA VENTURES VII (PARALLEL) LP

  • 10% Owner
 2,541,610 2015-04-02 0

PANORAMA CAPITAL, L.P.

  • 10% Owner
 No longer subject to file 2015-01-28 0

THOMAS, MCNERNEY & PARTNERS II L.P.

TMP ASSOCIATES II LP

TMP NOMINEE II, LLC

  • 10% Owner
 5,220,224 2014-05-14 0

ZISSON ALEX

TMP ASSOCIATES II LP

TMP NOMINEE II, LLC

  • Director
  • 10% Owner
 5,220,224 2014-05-14 0

THOMAS, MCNERNEY & PARTNERS II, LLC

  • Director
  • 10% Owner
 10,345,184 2014-05-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments